Regret after gender-affirming surgery is considered a rare outcome. There is a paucity of literature examining the incidence and/or etiology of surgical de-and re-transition. Coupled with the current issues in access and barriers for those seeking gender-affirming surgery, research in this field is extremely controversial. There are currently no professional guidelines or resources for providers who encounter patients who experience regret and/or seek detransition. In this paper the authors try to answer the question of how frequently gender surgeons are confronted with patients seeking the above care and what the current controversies are surrounding this very important topic.
BACKGROUND:
Regret after gender-affirming surgery is considered a rare outcome. There is a paucity of literature examining the incidence and/or etiology of surgical de-and re-transition. Coupled with the current issues in access and barriers for those seeking gender-affirming surgery, research in this field is extremely controversial. There are currently no professional guidelines or resources for providers who encounter patients who experience regret and/or seek detransition. In this paper the authors try to answer the question of how frequently gender surgeons are confronted with patients seeking the above care and what the current controversies are surrounding this very important topic.
METHODS:
An anonymous survey was sent to all surgeons who registered for the WPATH conference in 2016 and USPATH conference in 2017. We asked respondents to report the number of patients encountered who expressed regret or sought detransition, the characteristics of the patients, surgical history, reasons cited for detransition, and whether any reversal procedures were performed. The responses were analyzed using descriptive statistics.
RESULTS: 46 surgeons (30%) responded to the survery. 67% of providers have been in practice for greater than 10 years and most surgeons practice in the United States (69%) followed by Europe (22%). Surgeons were asked to select a range representing the number of transgender patients they have surgically treated, and this amounted to a cumulative number of approximately 22,725 patients treated by the cohort. 49% of respondents had never encountered a patient who regretted their gender transition or were seeking detransition care. 12 providers encountered 1 patient with regret and the rest encountered more than one patient. This amounted to a total of 62 patients. There were 13 patients who regretted chest surgery and 45 patients who regretted genital surgery. The composition of the patients who sought detransition is as follows: 16 trans-men, 37 trans-women, and 6 non-binary patients. The most common reason cited for detransition was change in gender identity (22 patients) followed by rejection or alienation from family or social support (8 patients) and difficulty in romantic relationships (7 patients). Chronic post-operative pain was also cited as a reason for detransition. 7 trans-women who sought detransition had vaginal stenosis, 2 had rectovaginal fistulae, and 3 had chronic genital pain. 2 trans-men who sought detransition had a urethral fistula and one had a urethral stricture. 9 of the 46 respondents performed a total of 38 detransition procedures.
91% of respondents stated they would require a mental health evaluation prior to detransition and 88% of respondents feel that WPATH SOC 8 should include a chapter on detransition.
CONCLUSION:
Regret after gender-affirming surgery is an exceedingly rare event. Reasons for regret or detransition are diverse, ranging from change in gender identity to societal and relationship pressures to post-surgical pain. It is not uncommon for detransition to be associated with surgical complications. Guidelines need to be developed to assist surgeons, patients, and payors in managing these rare events. PURPOSE: Non-healing lower extremity wounds are morbid and debilitating. If not treated appropriately, these wounds can lead to chronic complications, oftentimes necessitating numerous debridements and reoperations. Technological advancements have been implemented to the current treatment paradigm to promote a healthy granular wound bed and re-epithelization. The aim of this study was to critically assess wound healing outcomes following direct, low-frequency, high-intensity, ultrasonic debridement for non-healing lower extremity wounds, in a complex patient population.
Institutional Experience with Ultrasonic

METHODS:
A retrospective analysis of 107 lower extremity wounds were identified in 68 patients, who underwent treatment with a direct, low-frequency (22.4kHz), highintensity (~60 W/cm 2 ) ultrasonic device at the University of Pennsylvania between January 2010 and January 2016. Eighty-two wounds in fifty-one patients met inclusion criteria and were retrospectively reviewed. Wound healing outcomes were assessed at 180-day post-ultrasonic debridement. Descriptive statistics, cost, and univariate analysis were conducted for analysis.
RESULTS:
Mean age was 57.0 years and average BMI was 30.8kg/m 2 . 43.1% (n=22) of patients presented with more than 1 lower extremity wound. Primary wound location was ankle to knee region at 72% (n=59), followed by foot (23%, n=19), and knee to hip or gluteal region (5%, n=4). The patient population had several comorbidities that have been shown to decrease wound healing 1 , such as smoking (47%, n=24), hypertension (76%, n=38), diabetes (45%, n=23), and peripheral vascular disease (51%, n=26). These chronic wounds persisted for an average of 1,013 days with an average wound size of 9.0cm x 7.4cm. At 180-days postultrasonic debridement, 60% (n=49) of patients had improved wound healing (greater than 50% wound reduction). Readmission (47%, n=24) and reoperation (45%, n=23) rates were divided by encounter type: further wound healing or wound complication treatment. Readmission for wound healing (70%, n=39) was primarily for further debridements (41%, n=16). Whereas, wound infection (30%, n=7) was the most common readmission for wound complications (30%, n=17). Ninety-six percent (n=51) or reoperations consisted of treatments for further wound healing. Average length of hospital stay was 9.1 days.
CONCLUSION:
The use of a direct, low-frequency, highintensity, ultrasonic debridement tool provides beneficial wound-healing outcomes and preliminary improvements in time-to-healing. By showing positive findings at 180-days post-debridement, this study lays the foundation for future comparative studies to assess long-term outcomes of ultrasonic debridement, in conjunction with other wound debridement modalities. In a complex patient population, our results suggest that ultrasonic surgical debridement is a safe and effective adjunctive therapy in the management of chronic wound healing.
